Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.360
-0.170 (-4.82%)
Jan 21, 2026, 3:56 PM CET
Scandinavian ChemoTech AB Revenue
Scandinavian ChemoTech AB had revenue of 3.32M SEK in the quarter ending September 30, 2025, with 121.75% growth. This brings the company's revenue in the last twelve months to 11.68M, up 132.07% year-over-year. In the year 2024, Scandinavian ChemoTech AB had annual revenue of 6.57M with 132.67% growth.
Revenue (ttm)
11.68M
Revenue Growth
+132.07%
P/S Ratio
7.06
Revenue / Employee
11.68M
Employees
6
Market Cap
82.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.57M | 3.74M | 132.67% |
| Dec 31, 2023 | 2.82M | 2.35M | 496.62% |
| Dec 31, 2022 | 473.00K | -2.11M | -81.70% |
| Dec 31, 2021 | 2.59M | 1.17M | 82.81% |
| Dec 31, 2020 | 1.41M | -3.24M | -69.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |